Primary Site >> Colorectal Cancer

Gene >> ARL4C

Journal: Gan To Kagaku Ryoho. 1988 Apr;15(4 Pt 2-1):788-96.
Title: [Adoptive immunotherapy of malignant disease using LAK cells].
Author: Kimoto, Y|Taguchi, T
PMID: 3260466
Journal: Nihon Gan Chiryo Gakkai Shi. 1989 May 20;24(5):1027-33.
Title: [Potent effects of the prostaglandin synthesis inhibitor indomethacin on the cellular immune response in gastrointestinal cancer patients].
Author: Koyama, H|Narisawa, T|Kodama, M|Ishikawa, K|Kusaka, H|Yamazaki, Y|Koyama, K
PMID: 2778378
Journal: Onkologie. 1990 Dec;13(6):416-22.
Title: The clinical significance of interleukin-2.
Author: Bergmann, L
PMID: 2092277
Journal: Int J Cancer. 1990 Dec 15;46(6):1021-8.
Title: Lymphokine-activated killer cell cytotoxicity against human colon carcinomas enhanced by monoclonal antibody D612.
Author: Pendurthi, T K|Parker, R|Schlom, J|Primus, F J
PMID: 2123477
Journal: Cancer Immunol Immunother. 1990;31(4):231-5.
Title: Granulocyte-monocyte colony-stimulating-factor augments the interleukin-2-induced cytotoxic activity of human lymphocytes in the absence and presence of mouse or chimeric monoclonal antibodies (mAb 17-1A).
Author: Masucci, G|Ragnhammar, P|Wersall, P|Mellstedt, H
PMID: 2199042
Journal: Gan To Kagaku Ryoho. 1990 Apr;17(4 Pt 2):902-6.
Title: [Immunotherapy and quality of life].
Author: Ochiai, T|Suzuki, T|Gunji, Y|Okuyama, K|Koide, Y|Isono, K
PMID: 2344201
Journal: Nat Immun Cell Growth Regul. 1991;10(6):308-19.
Title: Adjuvant adoptive immunotherapy with IL2 and lymphocytes from tumor-bearing mice: in vitro tumor-stimulated lymphocytes are more effective than LAK cells.
Author: Rodolfo, M|Salvi, C|Bassi, C|Rovetta, G|Melani, C|Colombo, M P|Parmiani, G
PMID: 1787836
Journal: J Immunother (1991). 1991 Oct;10(5):297-306.
Title: Immunological effects of levamisole in vitro.
Author: Schiller, J H|Lindstrom, M|Witt, P L|Hank, J A|Mahvi, D|Wagner, R J|Sondel, P|Borden, E C
PMID: 1790137
Journal: Nihon Geka Gakkai Zasshi. 1991 Sep;92(9):1229-33.
Title: [Splenic or hepatic arterial injections of interleukin-2 with chemotherapeutic agents for hepatic metastases].
Author: Okuno, K|Onishi, H|Nakajima, I|Shirayama, Y|Hirohata, T|Ozaki, M|Yasutomi, M
PMID: 1944193
Journal: Gan To Kagaku Ryoho. 1992 Aug;19(10 Suppl):1453-6.
Title: [Significance of antitumor effects and immunological response on endogenously induced LAK therapy for primary or metastatic liver tumor].
Author: Miya, K|Saji, S|Furuta, T|Azuma, S|Umemoto, T|Takao, H|Katou, M|Kanno, A|Kaneda, N|Yamawaki, Y
PMID: 1530292
Journal: Biotherapy. 1992;4(4):257-65.
Title: Clinical trials of intrasplenic arterial infusion of interleukin-2 (IS-IL-2) to patients with advanced cancer.
Author: Okuno, K|Ohnishi, H|Koh, K|Shindo, H|Yoshioka, H|Yasutomi, M
PMID: 1622739
Journal: Nihon Geka Hokan. 1993 May 1;62(3):145-52.
Title: Study of effect of surgical stress on immunity in patients with gastrointestinal cancer.
Author: Tanabe, H
PMID: 8274052
Journal: Int J Cancer. 1993 Feb 1;53(3):409-17.
Title: Analysis of the relationship between stage of differentiation and NK/LAK susceptibility of colon carcinoma cells.
Author: Blottiere, H M|Zennadi, R|Gregoire, M|Aillet, G|Denis, M G|Meflah, K|Le Pendu, J
PMID: 8428794
Journal: Zhonghua Zhong Liu Za Zhi. 1994 Nov;16(6):428-31.
Title: [Observation of the effects of LAK/IL-2 therapy combining with Lycium barbarum polysaccharides in the treatment of 75 cancer patients].
Author: Cao, G W|Yang, W G|Du, P
PMID: 7720497
Journal: Cancer Biother. 1994 Fall;9(3):183-209.
Title: The clinical experience with interleukin-2 in cancer therapy.
Author: Dillman, R O
PMID: 7820182
Journal: Eur J Surg Oncol. 1995 Jun;21(3):254-60.
Title: Effect of essential fatty acids on natural cytotoxicity in patients with colorectal cancer.
Author: Purasiri, P|Ashby, J|Heys, S D|Eremin, O
PMID: 7781792
Journal: Bull Cancer. 1996 Mar;83(3):218-26.
Title: [Vaccination with genetically modified IL-2 secreting cells in a rat model of colonic carcinoma].
Author: Patry, Y|Meflah, K|Le Pendu, J
PMID: 8695924
Journal: Scand J Immunol. 1997 Feb;45(2):182-92.
Title: Interleukin-7 (IL-7) in colorectal cancer: IL-7 is produced by tissues from colorectal cancer and promotes preferential expansion of tumour infiltrating lymphocytes.
Author: Maeurer, M J|Walter, W|Martin, D|Zitvogel, L|Elder, E|Storkus, W|Lotze, M T
PMID: 9042431
Journal: Immunol Lett. 1997 Feb;55(2):69-78.
Title: Extracellular adenosine 5' triphosphate involvement in the death of LAK-engaged human tumor cells via P2X-receptor activation.
Author: Correale, P|Tagliaferri, P|Guarrasi, R|Caraglia, M|Giuliano, M|Marinetti, M R|Bianco, A R|Procopio, A
PMID: 9143936
Journal: J Cancer Res Clin Oncol. 1997;123(8):420-8.
Title: Interleukin-2-activated killer cell activity in colorectal tumor patients: evaluation of in vitro effects by prothymosin alpha1.
Author: Eckert, K|Grunberg, E|Immenschuh, P|Garbin, F|Kreuser, E D|Maurer, H R
PMID: 9292704
Journal: Russ J Immunol. 1997 Dec;2(3-4):167-176.
Title: IL-2-Activated Killer Cells and Native Cytokines in Treatment of Patients with Advanced Cancer.
Author: Ostanin, Alexander A.|Chernykh, Helena R.|Leplina, Olga Y.|Shevela, Ekaterina Ya.|Niconov, Sergey D.|Kozlov, Vladimir A.
PMID: 12687071
Journal: Int J Oncol. 1998 Apr;12(4):957-63.
Title: Docetaxel treatment of HT-29 colon carcinoma cells reinforces the adhesion and immunocytotoxicity of peripheral blood lymphocytes in vitro.
Author: Grunberg, E|Eckert, K|Maurer, H R
PMID: 9499461
Journal: Cancer Immunol Immunother. 2006 Jun;55(6):699-707.
Title: Morphological appearance, content of extracellular matrix and vascular density of lung metastases predicts permissiveness to infiltration by adoptively transferred natural killer and T cells.
Author: Yang, Q|Goding, S|Hagenaars, M|Carlos, T|Albertsson, P|Kuppen, P|Nannmark, U|Hokland, M E|Basse, P H
PMID: 16047144
Journal: Zhonghua Wei Chang Wai Ke Za Zhi. 2009 Jul;12(4):371-3.
Title: [Study on radiation sensitivity of colorectal cancer cells using gene expression profile].
Author: Yang, Xiao-dong|Xing, Chun-gen|Gong, Wei|Zhou, Li-ying|Wu, Yong-you|Zhao, Kui
PMID: 19598022
Journal: Oncol Res. 2011;19(12):543-54.
Title: Decrease of the regulatory T-cell population by adoptive T-cell transfer in a mouse colorectal cancer transplant model.
Author: Matsumoto, Tsuguhiro|Kokura, Satoshi|Ishikawa, Takeshi|Funaki, Jun|Adachi, Satoko|Mori, Koji|Sakamoto, Naoyuki|Katada, Kazuhiro|Kamada, Kazuhiro|Yagi, Nobuaki|Handa, Osamu|Takagi, Tomohisa|Uchiyama, Kazuhiko|Naito, Yuji|Yosikawa, Toshikazu
PMID: 22812187
Journal: Oncogene. 2015 Sep 10;34(37):4834-44.
Title: Arl4c expression in colorectal and lung cancers promotes tumorigenesis and may represent a novel therapeutic target.
Author: Fujii, S|Matsumoto, S|Nojima, S|Morii, E|Kikuchi, A
PMID: 25486429
Journal: Cancer Biomark. 2016;16(2):253-7.
Title: Clinical and prognostic significance of Arl4c expression in colorectal cancer.
Author: Chen, Xiaobo|Su, Zhaoliang|Wang, Shengjun|Xu, Huaxi
PMID: 26756615